Wesper Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $17.9M

  • Investors
  • 18

Wesper General Information

Description

Developer of a topical patch designed to make clinical-grade sleep analysis and longitudinal care accessible. The company provides wireless biometric patches, automated diagnostic analysis, and integrated clinical portals to monitor respiration, oxygen levels, heart rate, and snoring, enabling medical providers, dentists, and patients to diagnose sleep disorders, manage long-term treatment, and improve their sleep quality.

Contact Information

Website
www.wesper.co
Formerly Known As
Tatch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 234 Fifth Avenue
  • New York, NY 10001
  • United States
+1 (917)
Primary Industry
Therapeutic Devices
Other Industries
Application Software
Monitoring Equipment
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, TMT, Mobile
Corporate Office
  • 234 Fifth Avenue
  • New York, NY 10001
  • United States
+1 (917)

Wesper Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wesper Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 14-Jul-2026 $17.9M Completed Generating Revenue
5. Accelerator/Incubator 07-May-2023 Completed Generating Revenue
4. Later Stage VC (Series A) 21-Nov-2022 Completed Generating Revenue
3. Seed Round 26-Feb-2020 Completed Generating Revenue
2. Accelerator/Incubator 18-Oct-2019 $1.38M Completed Startup
1. Seed Round 01-Aug-2016 $1.38M $1.38M Completed Startup
To view Wesper’s complete valuation and funding history, request access »

Wesper Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-3
Series B-2
Series B-1
Series A-2
Series A-1
Series A
Seed-4
Seed-3
Seed-2 654,597 $0.000010 8% $0.27 $0.27 1x $0.27 1.32%
Seed-1 3,947,863 $0.000010 8% $1.08 $1.08 1x $0.79 10.9%
To view Wesper’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Wesper Patents

  • 40

    Total Documents Applications and Grants

  • Total Patents Families

  • 24

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Wesper Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-215062-S Pulse oximeter Active 13-May-2022
US-D1029268-S1 Pulse oximeter Active 13-May-2022
EP-4504048-A1 Systems, methods, and components thereof relating to respiration severity measurement, assessment, and treatment Inactive 08-Apr-2022
EP-4504048-A4 Systems, methods, and components thereof relating to respiration severity measurement, assessment, and treatment Inactive 08-Apr-2022
US-20250248649-A1 Systems, methods, and components thereof relating to respiration severity measurement, assessment, and treatment Pending 08-Apr-2022 A61B5/4818
To view Wesper’s complete patent history, request access »

Wesper Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wesper Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aphelion Capital Venture Capital Minority
CareQuest Innovation Partners Accelerator/Incubator Minority
Hatteras Venture Partners Venture Capital Minority
Pentland Ventures Venture Capital Minority
AgeTech Collaborative from AARP Accelerator/Incubator
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Wesper FAQs

  • When was Wesper founded?

    Wesper was founded in 2016.

  • Where is Wesper headquartered?

    Wesper is headquartered in New York, NY.

  • What is the size of Wesper?

    Wesper has 33 total employees.

  • What industry is Wesper in?

    Wesper’s primary industry is Therapeutic Devices.

  • Is Wesper a private or public company?

    Wesper is a Private company.

  • What is the current valuation of Wesper?

    The current valuation of Wesper is .

  • What is Wesper’s current revenue?

    The current revenue for Wesper is .

  • How much funding has Wesper raised over time?

    Wesper has raised $33.1M.

  • Who are Wesper’s investors?

    Aphelion Capital, CareQuest Innovation Partners, Hatteras Venture Partners, Pentland Ventures, and AgeTech Collaborative from AARP are 5 of 18 investors who have invested in Wesper.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process